ContextVision AB (publ) (0L8Z) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Contextvision Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.597 Welcome to Context Vision and welcome to the presentation of our second quarter results. 00:00:04.597 -- 00:00:10.285 Today with Richard, our CFO, myself, Gerald, we have an agenda with three 00:00:10.285 -- 00:00:16.213 agenda items, a business update, a deep dive into the financial development 00:00:16.213 -- 00:00:21.360 and a brief summary and outlook. Without further ado, let's look into the business update 00:00:21.360 -- 00:00:24.582 and the second quarter 2025. 00:00:24.905 -- 00:00:29.932 We continue to expand our partnership network to advance into quantitative 00:00:29.932 -- 00:00:35.321 ultrasound and in the second quarter we have signed up University of Waterloo, InFace 00:00:35.321 -- 00:00:38.345 Solutions and Amra Medical. 00:00:38.345 -- 00:00:43.012 We have attended a conference CMEF in Shanghai in April. 00:00:43.012 -- 00:00:48.118 We have signed up a new customer and a new platform also in Asia and that 00:00:48.118 -- 00:00:53.204 was within specialty ultrasound. And I'm very excited that we have released in the second 00:00:53.204 -- 00:00:58.790 quarter a major revamped upgrade as well as a completion 00:00:58.790 -- 00:01:04.397 of an entirely new software platform with a new architecture that will be the foundation 00:01:04.397 -- 00:01:10.248 for an entire new series of products that are going to be clinically focused. 00:01:10.248 -- 00:01:15.576 Now looking at the financials, we saw a decline in revenues to 28.6 00:01:15.576 -- 00:01:21.424 million SIC and that's a 10% decline compared to previous year. 00:01:21.424 -- 00:01:26.752 EBITDA amounted to 5.1 million SIC and that is adjusted for investments into data 00:01:26.752 -- 00:01:31.038 quality and corresponds to a 7.8% EBITDA margin. 00:01:31.038 ...